Pasar al contenido principal

DESARROLLO DE NUEVAS TERAPIAS FRENTE AL VIRUS DEL NILO OCCIDENTAL BASADAS EN FACTORES DEL HOSPEDADOR, BLOQUEANTES DE LA ENTRADA E INHIBIDORES DE LA POLIMERASA VIRICA

PID2022-137372OR-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Development of a luminescence-based method for measuring West Nile Virus MTase activity and its application to screen for antivirals

  • Álvarez-Mínguez, Alejandra
  • Río, Natalia del
  • Blázquez, Ana-Belén
  • Casanova, Elena
  • Orduña, José-María
  • Camarero, Patricia
  • Hurtado-Marcos, Carolina
  • Águila, Carmen del
  • Peréz-Pérez, María-Jesús
  • Martín-Acebes, M. A.
  • Agudo, Rubén
West Nile virus (WNV) is a flavivirus responsible for causing febrile illness and severe neurological diseases, with an increasing impact on human health around the world. However, there is still no adequate therapeutic treatment available to struggle WNV infections. Therefore, there is an urgent need to develop new techniques to accelerate the discovery of drugs against this pathogen. The main protein implicated in the replication of WNV is the non-structural protein 5 (NS5). This multifunctional protein contains methyltransferase (MTase) activity involved in the capping formation at the 5′-end of RNA and the methylation of internal viral RNA residues, both functions being essential for viral processes, such as RNA translation and escape from the innate immune response. We have developed a straightforward luminescence-based assay to monitor the MTase activity of the WNV NS5 protein with potential for high-throughput screening. We have validated this method as a sensitive and suitable assay for the identification of WNV MTase inhibitors assessing the inhibitory effect of the broad MTase inhibitor sinefungin, a natural nucleoside analog of the universal methyl donor S-adenosyl methionine (SAM). The screening of a small series of purine derivatives identified an adenosine derivative as a dose-dependent inhibitor of the MTase activity. The antiviral efficacy of this compound was further confirmed in WNV infections, displaying a measurable antiviral effect. This result supports the utility of this novel method for the screening of inhibitors against WNV MTase activity, which can be of special relevance to the discovery and development of therapeutics against WNV., This work was supported by Ministerio de Ciencia e Innovación y Universidades, Agencia Estatal de Investigación MICIU/AEI/10.13039/ 501,100,011,033 under grants PID2020–115432RB-I00 (to RA), PID2019–105117RR-C21 (to MAM-A), PID2019–105117RR-C22 (to MJP-P), PID2022–137372OR-C21 (to MAM-A) and PID2022–137372ORC21 (to M-JP-P), by the European Commission—Next Generation EU through CSIC’s Global Health Platform (PTI Salud Global) (to M-JP-P and MAM-A) and by CSIC-PIE202380E090 (to M-JP-P). AA-M. is the recipient of an FPU-predoctoral fellowship FPU22/03025 granted by MICIU/AEI/10.13039/501,100,011,033 and the FSE+. The funders did not participate in the study design, data collection and interpretation, or the decision to submit the work for publication., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lipid-targeting antiviral strategies: Current state and future perspectives

  • Blázquez, Ana B.
  • Mingo-Casas, Patricia
  • Quesada, Ernesto
  • Priego, Eva María
  • Peréz-Pérez, María-Jesús
  • Martín-Acebes, M. A.
There is an urgent need for antiviral compounds effective against currently known and future viral threats. The development of host-targeting antivirals (HTAs) appears as an alternative strategy to fight viral infections minimizing the potential of resistant mutant development and potentially leading to the identification of broad-spectrum antiviral agents. Among the host factors explored for HTA strategy, lipids constitute an attractive target as many viruses, even genetically diverse, hijack specific lipids during their lifecycle. Multiple repurposing efforts have been performed to analyze the antiviral properties of lipid-targeting compounds. These studies include the analysis of the effects of cholesterol lowering drugs such as statins, cholesterol transport inhibitors, sphingolipid modulators, de novo lipogenesis inhibitors blocking fatty acid synthesis, compounds targeting glycerophospholipids or drugs interfering with lipid droplet metabolism. This review is focused on the current status of lipid-based or lipid-targeting antiviral strategies and their potential for the development of antiviral therapies, with special emphasis on those studies that have reached advanced stages of development such as efficacy studies in animal models or clinical trials. Whereas there is still a long way to go, multiple proof-of-concept studies and clinical evidence reinforce the therapeutic potential of these strategies warranting their further development into effective antiviral therapies., This work was supported by the Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 under Grants PID2022-137372OR-C21 (to MAMA) and PID2022-137372OR-C22 (MJPP and EMP) and by the European Commission—NextGenerationEU through CSIC's Global Health Platform (PTI Salud Global). MJPP acknowledges the financial support of the CSIC Intramural project PIE202380E090. PMC was supported by an FPI fellowship from AEI/10.13039/501100011033 under Grant PRE2020-093374., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Reprogramming of liver metabolism during West Nile virus infection unveils novel aspects of disease pathophysiology

  • Mingo-Casas, Patricia
  • Blázquez, Ana-Belén
  • Casas, Josefina
  • Esteban, Ana
  • Escribano-Romero, Estela
  • Sánchez-Cordón, Pedro J.
  • Jiménez de Oya, Nereida
  • Saiz, Juan-Carlos
  • Martín-Acebes, M. A.
[Data availability] The RNA-seq datasets generated during the current study have been deposited in the Gene Expression Omnibus with the primary accesion code GSE242981., [Background] West Nile virus (WNV) is a neurotropic mosquito-borne flavivirus responsible for outbreaks of encephalitis and meningitis worldwide. About 20% of infected patients exhibit abnormal liver function tests, although the participation of this organ in the pathophysiology of the disease remains unclear. To fill this gap, this study explores changes in liver metabolism during WNV infection., [Methods] Given the relevance of the liver as a major immune and metabolic organ, the changes in response to WNV infection were analyzed in the mouse model combining transcriptomics, lipidomics and histopathological analyses., [Results] Despite the absence of detectable viral replication in the liver, infection resulted in hepatic transcriptomic reprogramming that affected inflammation, immunity, biological oxidation and lipid metabolisms. Changes in the expression of genes related to glutathione metabolism, detoxification reactions, fatty acid metabolism (fatty acid oxidation and fatty acyl-CoA biosynthesis), phospholipid synthesis (phosphatidylcholine and phosphatidylethanolamine), sphingolipid synthesis, sterol metabolism and lipid droplet organization were identified. The reduction in glutathione in the liver of infected animals was confirmed and lipidomic analyses showed an increase in the content of sphingolipids, triacylglycerols and cholesteryl esters. A decrease in the cholesterol, phosphatidylcholine and phosphatidylethanolamine levels was also observed. Moreover, histopathological findings supported the development of steatosis in one-third of WNV-infected animals., [Conclusions] The discovery of these underestimated metabolic aspects of the infection repurposes the impact of WNV on liver function. These results will contribute to a better understanding of the physiopathology of the disease and warrant special attention to liver function during WNV infection., This study was supported by Spanish Ministry of Science and Innovation AEI/https://doi.org/10.13039/501100011033 and FEDER, EU under grants PID2019-105117RR-C21 (to MAMA), PID2022-137372OR-C21 (to MAMA), PID2020-119195RJ-I00 (to NJO), Community of Madrid under grant TEC-2024/BIO-66/SALAINDEC-CM (to MAMA) and by the European Commission– NextGenerationEU through CSIC's Global Health Platform (PTI Salud Global). PMC was supported by a FPI fellowship from AEI/https://doi.org/10.13039/501100011033 under grant PRE2020-093374. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Neutral sphingomyelinase 2 inhibition alters inflammatory gene expression signatures in the brain of mice infected with West Nile virus

  • Mingo-Casas, Patricia
  • Álvarez-Fernández, Hadrián
  • Blázquez, Ana-Belén
  • Esteban, Ana
  • Escribano-Romero, Estela
  • Jiménez de Oya, Nereida
  • Calvo-Pinilla, Eva
  • Peréz-Pérez, María-Jesús
  • Priego, Eva María
  • Martín-Acebes, Miguel A
West Nile virus (WNV) is a neurotropic flavivirus transmitted by the bites of infected mosquitoes. Severe forms of the disease include meningitis, encephalitis, acute flaccid paralysis, or even death, and survivors develop long-lasting sequelae. The damage induced by WNV does not only stem from viral multiplication but also arises from immune-related pathology linked to neuroinflammation. Certain sphingolipids are key players in WNV infection, neurodegenerative diseases and inflammatory disorders. Neutral sphingomyelinase 2 (nSMase2), catalyzes the conversion of sphingomyelin into ceramide and is essential for flavivirus multiplication. Thus, nSMase2 constitutes a promising therapeutic target for the development of dual-acting antiviral and anti-inflammatory therapies against WNV. The effect of an orally bioavailable and brain-penetrating prodrug of the potent nSMase2 inhibitor DPTIP (DPTIP-P1) was studied in WNV-infected mice. While no reduction in the viral load in the brain of infected animals was observed, WNV-induced expression of inflammatory markers was modulated, resulting in a reduced IL-1β expression in brain. Transcriptomic analyses revealed that treatment with the DPTIP prodrug also modulated the expression of various genes related to immune cell function without altering antiviral innate response. Among others, DPTIP-P1 reduced the expression of Lyz2, an inducible genetic marker associated with macrophage infiltration, and modified the expression of genes related to T cell activation such as Trbc1 and Ptnp22. These results identify nSMase2 inhibitors as a new type of immune modulators of WNV infection. The neuroprotective effects exerted by DPTIP-P1 could contribute to mitigate WNV-induced neuroinflammation and sequelae., This work was supported by the Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 under Grants PID2019- 105117RR-C21 (to MAMA), PID2019-105117RR-C22 (to MJPP) and PID2020-119195RJ-I00 (to NJO); Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 and FEDER, EU under grants PID2022-137372OR-C21 (to MAMA), PID2022-137372OR-C22 (MJPP and EMP), by Comunidad de Madrid under grant TEC-2024/BIO-66/ SALAINDEC-CM (to MAMA) and by the European Commission—NextGenerationEU through CSIC’s Global Health Platform (PTI Salud Global). PMC was supported by an FPI fellowship from AEI/ 10.13039/501100011033 under Grant PRE2020-093374. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Fluorescence-based biosensors for West Nile virus detection

  • Blázquez, Ana-Belén
  • Saiz, Juan Carlos
  • Herrero, Laura
  • Sánchez-Céspedes, Javier
  • Vázquez, Ana
  • Cisneros, José Miguel
  • Martín-Acebes, M. A.
  • Jiménez de Oya, Nereida
Flaviviruses are emerging pathogens, mostly transmitted by arthropod vectors, responsible for human, animal, and zoonotic diseases. The emergence of flaviviruses has been favored in recent decades by factors related to climate change and globalization, which contribute to the arrival and establishment of their vectors in new geographic areas, thus promoting epidemic outbreaks and facilitating these viruses to become endemic in these areas. This is the case of the West Nile virus (WNV) in Europe, which affects its natural bird host populations and also accidental hosts such as humans and horses. Flaviviruses are antigenically related, which induces cross-reactivity, making their serological diagnosis difficult, especially in areas where several flaviviruses co-circulate. Here, we have developed WNV biosensors in which the enzymatic activity of the viral protease, expressed during infection, allows its detection using fluorescence-based techniques. These biosensors carry WNV-specific protease cleavage sites and show high specificity for the detection of both lineages 1 and 2, with limits of detection (LODs) ranging from 0.001-0.0001 MOI at 48 hours post-infection (h.p.i.). These LODs are even lower at 72 h.p.i. reaching as low as an MOI of 2.5 × 10−6. They are also capable of detecting, although with lower sensitivity, other flaviviruses such as dengue, Zika, and Usutu viruses, without showing reactivity against unrelated viruses. These biosensors have been validated in viral neutralization assays with sera from infected mice and humans, as well as in antiviral screening, with results comparable to those of currently used systems, showing significant potential as clinical and laboratory tools., This work was supported by the Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 under Grants [PID2020-119195RJ-I00] (to NJO) and [PID2022-137372OR-C21] (to MAMA), by Comunidad de Madrid under grant [TEC-2024/BIO-66/SALAINDEC-CM] (to MAMA), by the Instituto de Salud Carlos III Project PI19CIII_00014, and by the European Commission—NextGenerationEU through [CSIC’s Global Health Platform] (PTI Salud Global). The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Fluorescence-based biosensors for West Nile virus detection [Dataset]

  • Blázquez, Ana-Belén
  • Saiz, Juan Carlos
  • Herrero, Laura
  • Sánchez-Céspedes, Javier
  • Vázquez, Ana
  • Cisneros, José Miguel
  • Martín-Acebes, M. A.
  • Jiménez de Oya, Nereida
Flaviviruses are emerging pathogens, mostly transmitted by arthropod vectors, responsible for human, animal, and zoonotic diseases. The emergence of flaviviruses has been favored in recent decades by factors related to climate change and globalization, which contribute to the arrival and establishment of their vectors in new geographic areas, thus promoting epidemic outbreaks and facilitating these viruses to become endemic in these areas. This is the case of the West Nile virus (WNV) in Europe, which affects its natural bird host populations and also accidental hosts such as humans and horses. Flaviviruses are antigenically related, which induces cross-reactivity, making their serological diagnosis difficult, especially in areas where several flaviviruses co-circulate. Here, we have developed WNV biosensors in which the enzymatic activity of the viral protease, expressed during infection, allows its detection using fluorescence-based techniques. These biosensors carry WNV-specific protease cleavage sites and show high specificity for the detection of both lineages 1 and 2, with limits of detection (LODs) ranging from 0.001-0.0001 MOI at 48 hours post-infection (h.p.i.). These LODs are even lower at 72 h.p.i. reaching as low as an MOI of 2.5 × 10−6. They are also capable of detecting, although with lower sensitivity, other flaviviruses such as dengue, Zika, and Usutu viruses, without showing reactivity against unrelated viruses. These biosensors have been validated in viral neutralization assays with sera from infected mice and humans, as well as in antiviral screening, with results comparable to those of currently used systems, showing significant potential as clinical and laboratory tools., This work was supported by the Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 under Grants [PID2020-119195RJ-I00] (to NJO) and [PID2022-137372OR-C21] (to MAMA), by Comunidad de Madrid under grant [TEC-2024/BIO-66/SALAINDEC-CM] (to MAMA), by the Instituto de Salud Carlos III Project PI19CIII_00014, and by the European Commission—NextGenerationEU through [CSIC’s Global Health Platform] (PTI Salud Global). The funders had no role in study design, data collection, and interpretation, or the decision to submit the work for publication., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Fluorescence-based biosensors for West Nile virus detection [Dataset]

  • Jiménez de Oya, Nereida
This study develops and validates fluorescence-based biosensors that detect West Nile virus (WNV) infection through the activity of the viral protease. The biosensors incorporate WNV-specific protease cleavage sites and enable highly specific detection of both WNV lineages 1 and 2, with limited but measurable sensitivity to other flaviviruses. The system shows no cross-reactivity with unrelated viruses. These biosensors were evaluated in viral neutralization assays using sera from infected mice and humans, as well as in antiviral screening assays, demonstrating performance comparable to standard diagnostic approaches. The platform offers rapid, quantitative, and reproducible detection of field viral isolates, providing advantages over traditional serological and molecular methods. This tool supports improved clinical diagnostics, antiviral testing, and research on flavivirus replication and virulence., This work was supported by the Spanish Ministry of Science and Innovation AEI/10.13039/501100011033 under Grants PID2020-119195RJ-I00 (to NJO) and PID2022-137372OR-C21 (to MAMA), by the Instituto de Salud Carlos III Project PI19CIII_00014, and by the European Commission—NextGenerationEU through CSIC’s Global Health Platform (PTI Salud Global)., Peer reviewed